藥物肽
Lixisenatide Acetate
CAS No.:
320367-13-3
Molecular formula:
C215H347N61O65S
Molecular Weight:
4858.53
Amino acids sequence:
H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2
Application:
Lixisenatide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. Therapy with lixisenatide has not been associated with serum enzyme elevations or with episodes of clinically apparent liver injury.
Notes: For research use only
聯(lián)系我們
微信公眾平臺
江蘇省南京市江北新區(qū)天圣路22號新材料科技園 New Material Technology Park, No. 22 Tiansheng Road, Jiangbei New District, Nanjing City, Jiangsu Province |
|
smalltao.cn | |
[email protected] | |
+86 25 86557173/ 58067593/ 83751537 |
南京萊昂生物科技有限公司
Leon (Nanjing) Biotechnology Co., Ltd.
南京萊昂生物科技有限公司 版權(quán)所有(C)2021 備案序號:蘇ICP備18004987號-1